The TAM-TB assay, a test that has been found by a new proof-of-concept study, is the first reliable immunodiagnostic assay to detect active tuberculosis in children.
This assay is a major advance for the diagnosis of tuberculosis, particularly in tuberculosis-endemic regions. The new blood test, which provides a fast and accurate tool to diagnose tuberculosis in children, is a sputum-independent blood test and makes use of an immunological phenomenon during tuberculosis disease.
Tuberculosis is a serious public health problem especially in low-resource countries and about 1 million children per year develop tuberculosis worldwide.
The study was published in Lancet Infectious Diseases.